North America Next Generation Sequencing Market

The North America next generation sequencing market is expected to reach US$ 10,733.0 Mn in 2025 from US$ 2,378.5 Mn in 2017. The market is estimated to grow with a CAGR of 20.7% from 2018-2025.

In recent years, the cases of cancer has been increasing tremendously and the trend is anticipated to remain the same in the upcoming years. Change in lifestyle has resulted in more exposure to oncogenic factors. In 2015, The American Cancer Society estimated 1,658,370 cancer cases to be detected in the US. Cancer can be cured if diagnosed and treated at an initial stage. Cancer sequencing using next-generation sequencing (NGS) methods provides more information. Additionally, NGS also aids in diagnostics and treatment of cancer. Increase in cancer cases are expected to be a prime factor driving the demand for NSG market in the coming years.

Additionally, Biomarkers are medical signs that are indications of medical state observed from outside the patient. The biomarkers are used in clinical research and clinical practice. Next Generation Sequencing (NGS) is one of the most significant advances in genomic technologies with regards to oncogenic biomarker discovery and diagnostics. NGS helps in biomarker discovery for identification of genetic diseases. HiSeq2500 and MiSeq Illumina sequencers are used for biomarker discovery on a large scale. Precision medicine is the use of an individual’s genomic information to offer targeted treatment to the individual. Next generation sequencing technology is a key driver of precision medicine and has improved its accuracy, speed, and cost. NGS is capable of rapidly sequencing large sections of a person's genome and aids in formulation of precision medicine.
Biomarker discovery benefits in early diagnosis and differentiating in disease types. Whereas, precision medicine enables in treatment of the diseases NGS places a vital role in booth the application, giving it an array of opportunity in future.

US is expected to lead the market in the North America region owing to increasing organic and inorganic growth strategies in the country. Moreover, increasing focus of market players in the US and grants & funds by NIH is one of the major driving factor. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the North America region during the forecast period.

Exhibit: Mexico Next Generation Sequencing Market Revenue and Forecasts to 2025 (US$ Mn)

NORTH AMERICA NEXT GENERATION SEQUENCING - MARKET SEGMENTATION

By Product

• Consumables
• Services
• Platforms

By Technology

• Genome Sequencing
• Exome Sequencing
• Resequencing & Targeted Sequencing
• Other

By Application

• Diagnostics
• Drug Discovery
• Precision Medicine
• Others

By End User

• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Clinics
• Others

By Geography

• North America

  • US
  • Canada
  • Mexico

Company Profiles

• Illumina, Inc.
• Thermo Fisher
• Qiagen N.V.,
• Beijing Genomics Institute
• PerkinElmer, Inc.
• F.Hoffman-La Roche Ltd.
• Agilent Technologies
• Eurofins Scientific
• Oxford Nanopore Technologies Ltd.
• Macrogen Inc.

North America Next Generation Sequencing Strategic Insights

Strategic insights for the North America Next Generation Sequencing provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Next Generation Sequencing Report Scope

North America Next Generation Sequencing Regional Insights

The geographic scope of the North America Next Generation Sequencing refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.